{"blog": [], "keywords": [{"value": "Mergers, Acquisitions and Divestitures", "name": "subject", "rank": "1", "is_major": "N"}, {"value": "Suits and Litigation (Civil)", "name": "subject", "rank": "2", "is_major": "N"}, {"value": "Kirkland & Ellis", "name": "organizations", "rank": "3", "is_major": "N"}, {"value": "Mylan Inc", "name": "organizations", "rank": "4", "is_major": "N"}, {"value": "Teva Pharmaceutical Industries Ltd", "name": "organizations", "rank": "5", "is_major": "N"}], "web_url": "http://www.nytimes.com/2015/05/05/business/dealbook/mylan-case-puts-focus-on-waivers.html", "document_type": "article", "byline": {"person": [{"lastname": "HOLDING", "firstname": "Reynolds", "role": "reported", "organization": "", "rank": 1}], "original": "By REYNOLDS HOLDING"}, "type_of_material": "News", "multimedia": [], "section_name": "Business Day", "word_count": "373", "source": "The New York Times", "subsection_name": "DealBook", "lead_paragraph": "The drug maker sued its former lawyers at Kirkland & Ellis over advising Teva. The lawyers say Mylan agreed, but a court may rule such waivers unethical.", "pub_date": "2015-05-05T00:00:00Z", "news_desk": "Business", "headline": {"kicker": "Breakingviews", "main": "Mylan Case Puts Focus on Waivers", "content_kicker": "Breakingviews"}, "print_page": null, "snippet": "The drug maker sued its former lawyers at Kirkland & Ellis over advising Teva. The lawyers say Mylan agreed, but a court may rule such waivers unethical.", "_id": "5547c2db38f0d81a8df26525", "slideshow_credits": null, "abstract": null}